Methicillin-Resistant Staphylococcus aureus (MRSA) Infections (Infectious Disease) – Drugs in Development, 2021

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Resistant Staphylococcus aureus Infections – Drugs In Development, 2021, provides an overview of the Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease) pipeline landscape.MRSA infections that are acquired by persons who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-acquired MRSA (CA-MRSA) infections. Risk factors are hemodialysis, weakened immune system, admission to hospitals and wounds. Symptoms include skin rashes, fatigue, chest pain, fever and swelling. MRSA can be managed by the use of antibiotics and by maintaining hygienic conditions.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Methicillin-Resistant Staphylococcus aureus Infections – Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 6, 15, 11, 1, 66, 33 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 35 and 25 molecules, respectively.

Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease).

– The pipeline guide reviews pipeline therapeutics for Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Methicillin-Resistant Staphylococcus aureus Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies mentioned

AbbVie Inc

Acticule Life Sciences Ltd

AEON Medix Inc

AimMax Therapeutics Inc

AlphaMab Co Ltd

Amicrobe Inc

Amprologix Ltd

AnyGen Co Ltd

Aphios Corp

Aridis Pharmaceuticals Inc

Arietis Corp

Aurigene Discovery Technologies Ltd

Basilea Pharmaceutica Ltd

Bharat Biotech Ltd

Biomendics LLC

BioPlx Microbiomics Pvt Ltd

Bioseka UAB

Bioversys AG

Botanix Pharmaceuticals Ltd

Cadila Healthcare Ltd

Cantab Anti-infectives Ltd

Cellics Therapeutics Inc

Centivax Inc

Crestone Inc

CrystalGenomics Inc

CSA Biotechnologies LLC

Curza Global LLC

Daiichi Sankyo Co Ltd

Debiopharm International SA

DeNovaMed Inc

Destiny Pharma Plc

Eagle Pharmaceuticals Inc

Enesi Pharma Ltd

ESA Patentverwertungsagentur Sachsen-Anhalt GmbH

Exbaq LLC

Galenus Therapeutics Inc

GangaGen Biotechnologies Pvt Ltd

Genentech USA Inc

Global BioLife Inc Ltd

Helperby Therapeutics Group Ltd

Hsiri Therapeutics LLC

HyPharm GmbH

ImmunArtes LLC

Immupharma Plc

Inimmune Corp

Instituto Biomar SA

Integrated BioTherapeutics Inc

ioGenetics Inc

Johnson & Johnson

KBP Biosciences Co Ltd

Kurobe LLC

Lakewood-Amedex Inc

Lead Discovery Center GmbH

LegoChem Biosciences Inc

Lysimmune BioScience

Lyticon LLC

Lytix Biopharma AS

Mabwell Shanghai Bioscience Co Ltd

Madam Therapeutics BV

Matrisys Bioscience Inc

Meiji Seika Pharma Co Ltd

Melinta Therapeutics Inc

Merck & Co Inc

MGB Biopharma Ltd

Microbiotix Inc

MicuRx Pharmaceuticals Inc

Motif Bio Plc

Nabriva Therapeutics Plc

Naicons Srl

Neupharma Srl

Novabiotics Ltd

NovaDigm Therapeutics Inc

Novalex Therapeutics Inc

NovoBiotic Pharmaceuticals LLC

Olgram SAS

Olymvax Biopharmaceuticals Inc

Opal Biosciences Ltd

Oppilotech Ltd

Oragenics Inc

Oryn Therapeutics

Oxford Drug Design Ltd

Peptineo

Phico Therapeutics Ltd

Procarta Biosystems Ltd

Prommune Inc

Q2 Pharma Ltd

QureTech Bio AB

Recce Pharmaceuticals Ltd

Sano Chemicals Inc

Scandion Oncology AS

SciBac Inc

Sentinella Pharmaceuticals Inc

Shanghai Space Peptides Pharmaceutical Co Ltd

Sinsa Labs Inc

Skye Bioscience Inc

Soligenix Inc

Sorrento Therapeutics Inc

Synspira Therapeutics Inc

TaeJoon Pharmaceuticals Co Ltd

Taisho Pharmaceutical Holdings Co Ltd

TAXIS Pharmaceuticals Inc

TGV-Inhalonix Inc

Therapeutic Systems Research Laboratories Inc

Theravance Biopharma Inc

Trellis Bioscience Inc

Valevia UK Ltd

Venomyx Inc

Viosera Therapeutics

Vitas Pharma Research Pvt Ltd

VLP Biotech Inc

Wockhardt Ltd

XBiotech Inc

Yungjin Pharm Co Ltd

Zhuhai Trinomab Biotechnology Co Ltd

Table of Contents

Table of Contents

Introduction

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Overview

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Therapeutics Development

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Therapeutics Assessment

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Companies Involved in Therapeutics Development

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Drug Profiles

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Dormant Projects

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Discontinued Products

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Companies, 2021 (Contd..1)

Number of Products under Development by Companies, 2021 (Contd..2)

Number of Products under Development by Companies, 2021 (Contd..3)

Number of Products under Development by Companies, 2021 (Contd..4)

Number of Products under Development by Companies, 2021 (Contd..5)

Number of Products under Development by Universities/Institutes, 2021

Number of Products under Development by Universities/Institutes, 2021 (Contd..1)

Number of Products under Development by Universities/Institutes, 2021 (Contd..2)

Products under Development by Companies, 2021

Products under Development by Companies, 2021 (Contd..1)

Products under Development by Companies, 2021 (Contd..2)

Products under Development by Companies, 2021 (Contd..3)

Products under Development by Companies, 2021 (Contd..4)

Products under Development by Companies, 2021 (Contd..5)

Products under Development by Companies, 2021 (Contd..6)

Products under Development by Companies, 2021 (Contd..7)

Products under Development by Universities/Institutes, 2021

Products under Development by Universities/Institutes, 2021 (Contd..1)

Products under Development by Universities/Institutes, 2021 (Contd..2)

Number of Products by Stage and Target, 2021

Number of Products by Stage and Target, 2021 (Contd..1)

Number of Products by Stage and Target, 2021 (Contd..2)

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AbbVie Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Acticule Life Sciences Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AEON Medix Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AimMax Therapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AlphaMab Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Amicrobe Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Amprologix Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by AnyGen Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Aphios Corp, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Aridis Pharmaceuticals Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Arietis Corp, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Aurigene Discovery Technologies Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Basilea Pharmaceutica Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Bharat Biotech Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Biomendics LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by BioPlx Microbiomics Pvt Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Bioseka UAB, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Bioversys AG, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Botanix Pharmaceuticals Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Cadila Healthcare Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Cantab Anti-infectives Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Cellics Therapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Centivax Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Crestone Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by CrystalGenomics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by CSA Biotechnologies LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Curza Global LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Daiichi Sankyo Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Debiopharm International SA, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by DeNovaMed Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Destiny Pharma Plc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Eagle Pharmaceuticals Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Enesi Pharma Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by ESA Patentverwertungsagentur Sachsen-Anhalt GmbH, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Exbaq LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Galenus Therapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by GangaGen Biotechnologies Pvt Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Genentech USA Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Global BioLife Inc Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Helperby Therapeutics Group Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Hsiri Therapeutics LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by HyPharm GmbH, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by ImmunArtes LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Immupharma Plc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Inimmune Corp, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Instituto Biomar SA, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Integrated BioTherapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by ioGenetics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Johnson & Johnson, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by KBP Biosciences Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Kurobe LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Lakewood-Amedex Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Lead Discovery Center GmbH, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by LegoChem Biosciences Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Lysimmune BioScience, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Lyticon LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Lytix Biopharma AS, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Mabwell Shanghai Bioscience Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Madam Therapeutics BV, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Matrisys Bioscience Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Meiji Seika Pharma Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Melinta Therapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Merck & Co Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by MGB Biopharma Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Microbiotix Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by MicuRx Pharmaceuticals Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Motif Bio Plc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Nabriva Therapeutics Plc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Naicons Srl, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Neupharma Srl, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Novabiotics Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by NovaDigm Therapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Novalex Therapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by NovoBiotic Pharmaceuticals LLC, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Olgram SAS, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Olymvax Biopharmaceuticals Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Opal Biosciences Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Oppilotech Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Oragenics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Oryn Therapeutics, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Oxford Drug Design Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Peptineo, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Phico Therapeutics Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Procarta Biosystems Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Prommune Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Q2 Pharma Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by QureTech Bio AB, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Recce Pharmaceuticals Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sano Chemicals Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Scandion Oncology AS, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by SciBac Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sentinella Pharmaceuticals Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Shanghai Space Peptides Pharmaceutical Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sinsa Labs Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Skye Bioscience Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Soligenix Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Sorrento Therapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Synspira Therapeutics Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by TaeJoon Pharmaceuticals Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Taisho Pharmaceutical Holdings Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by TAXIS Pharmaceuticals Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by TGV-Inhalonix Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Therapeutic Systems Research Laboratories Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Theravance Biopharma Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Trellis Bioscience Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Valevia UK Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Venomyx Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Viosera Therapeutics, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Vitas Pharma Research Pvt Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by VLP Biotech Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Wockhardt Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by XBiotech Inc, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Yungjin Pharm Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Pipeline by Zhuhai Trinomab Biotechnology Co Ltd, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021 (Contd..1)

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021 (Contd..2)

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021 (Contd..3)

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021 (Contd..4)

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021 (Contd..5)

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021 (Contd..6)

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021 (Contd..7)

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Dormant Projects, 2021 (Contd..8)

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Discontinued Products, 2021

List of Figures

List of Figures

Number of Products under Development for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Top 10 Targets, 2021

Number of Products by Stage and Top 10 Targets, 2021

Number of Products by Top 10 Mechanism of Actions, 2021

Number of Products by Stage and Top 10 Mechanism of Actions, 2021

Number of Products by Top 10 Routes of Administration, 2021

Number of Products by Stage and Top 10 Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2960

Saved reports